tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

United Laboratories’ AGM Resolutions Passed, Affirming Strategic Direction

Story Highlights
United Laboratories’ AGM Resolutions Passed, Affirming Strategic Direction

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from The United Laboratories International Holdings ( (HK:3933) ) is now available.

The United Laboratories International Holdings Limited announced that all proposed resolutions at their 2025 Annual General Meeting were approved by shareholders. Key resolutions included the adoption of financial statements, declaration of dividends, re-election of directors, and granting of mandates related to company securities. This successful AGM reflects shareholder confidence and supports the company’s strategic direction.

The most recent analyst rating on (HK:3933) stock is a Hold with a HK$15.29 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.

More about The United Laboratories International Holdings

The United Laboratories International Holdings Limited is a company incorporated in the Cayman Islands, primarily engaged in the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, catering to various healthcare needs.

Average Trading Volume: 14,171,419

Technical Sentiment Signal: Buy

Current Market Cap: HK$29.11B

For detailed information about 3933 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1